Cargando…

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19

Detalles Bibliográficos
Autores principales:	Rodionov, Roman N, Biener, Anne, Spieth, Peter, Achleitner, Martin, Hölig, Kristina, Aringer, Martin, Mingrone, Geltrude, Corman, Victor M, Drosten, Christian, Bornstein, Stefan R, Tonn, Torsten, Kolditz, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009633/ https://www.ncbi.nlm.nih.gov/pubmed/33817676 http://dx.doi.org/10.1016/S2666-5247(21)00030-6

Ejemplares similares

Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
por: Tonn, Torsten, et al.
Publicado: (2020)

SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4(+) T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer
por: Odendahl, Marcus, et al.
Publicado: (2022)

Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma
por: von Rhein, Christine, et al.
Publicado: (2021)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Endocrine and metabolic link to coronavirus infection
por: Bornstein, Stefan R., et al.
Publicado: (2020)

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020)

Convalescent plasma transfusion for pregnant patients with COVID-19
por: Mastroianni, Antonio, et al.
Publicado: (2021)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
por: Franchini, Massimo, et al.
Publicado: (2023)

Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
por: Körper, Sixten, et al.
Publicado: (2021)

Impact of Different Bariatric Surgical Procedures on Insulin Action and β-Cell Function in Type 2 Diabetes
por: Ferrannini, Ele, et al.
Publicado: (2009)

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
por: Steiner, Sophie, et al.
Publicado: (2021)

High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
por: Huygens, Sammy, et al.
Publicado: (2023)

Efficacy of convalescent plasma therapy in immunocompromised patients with COVID-19: A case report
por: Casarola, Genni, et al.
Publicado: (2021)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
por: Achleitner, Martin, et al.
Publicado: (2023)

Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres
por: Gottlieb, Jens, et al.
Publicado: (2022)

Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)

Treatment–donation-stockpile dynamics in ebola convalescent blood transfusion therapy
por: Huo, Xi, et al.
Publicado: (2016)

Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
por: Roshandel, Elham, et al.
Publicado: (2021)

Convalescent plasma therapy in an immunocompromised patient with multiple COVID‐19 flares: a case report
por: Karaolidou, Frini, et al.
Publicado: (2021)

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
por: Senefeld, Jonathon W., et al.
Publicado: (2023)

SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
por: Corman, Victor M., et al.
Publicado: (2020)

One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
por: Körper, Sixten, et al.
Publicado: (2022)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

Effectiveness and feasibility of convalescent blood transfusion to reduce COVID-19 fatality ratio
por: Huo, Xi, et al.
Publicado: (2021)

Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective
por: Kanj, Saly, et al.
Publicado: (2021)

Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients
por: Weisser, Maja, et al.
Publicado: (2022)

Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19
por: Maiara Ferreira Barreto Pires, Bruna, et al.
Publicado: (2023)

Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
por: Beraud, Mickael, et al.
Publicado: (2022)

Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test
por: Panunzi, Simona, et al.
Publicado: (2010)

Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome
por: Chun, Sejong, et al.
Publicado: (2016)

Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?
por: Raffaelli, Marco, et al.
Publicado: (2015)

ANAPHYLACTIC SHOCK IN A PREGNANT PATIENT WITH COVID-19 IN THE SETTING OF CONVALESCENT PLASMA TRANSFUSION
por: Mallari, Margaret, et al.
Publicado: (2020)

Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan
por: Khan, Tehmina Nafees Sonia, et al.
Publicado: (2021)

Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review
por: Casman, Casman, et al.
Publicado: (2022)

Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?
por: Bornstein, Stefan R., et al.
Publicado: (2021)

Vaccination under TNF blockade - less effective, but worthwhile
por: Aringer, Martin
Publicado: (2012)

Lupus erkennen und gezielt behandeln
por: Aringer, Martin
Publicado: (2020)

Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2
por: Aringer, Martin
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lk3rahe1mo6hcqh1ao8u2hc596